Dáil Éireann Debate, Tuesday - 19 January 2010
330 Deputy Jan O’Sullivan asked the Minister for Health and Children if Lyme disease will be a notifiable illness in order to increase public awareness and assist in the speedy diagnosis and treatment of the disease; and if she will make a statement on the matter. [48445/09]
View answerLyme disease (also known as Lyme borelliosis) is an infection caused by a bacterium called Borrelia burgdorferi which is transmitted to humans by bites from ticks infected with the bacteria. The infection is generally mild affecting only the skin, but can sometimes be more severe involving other organs. Ramblers, campers and those who work in such areas especially if they come into contact with large animals are at greatest risk of being bitten by ticks and of going on to develop the disease.
Lyme disease is not a notifiable infectious disease in Ireland. This means that there is no legal requirement on doctors to report cases to their local Director of Public Health, so this makes estimates of incidence difficult. However, the schedule of infectious diseases is reviewed on a periodic basis and inclusion of Lyme disease will be considered in the future. A number of cases are diagnosed each year, but the true figure is unknown. However, research has determined that there are about 30 human cases per year in Ireland. In 2007, 71 specimens were confirmed positive for Lyme borreliosis, suggesting a crude incidence rate of 1.67 per 100,000 that year. A recent study in the west of Ireland at Galway University Hospital suggests that the disease incidence may be higher in the Galway area.
A fact sheet on Lyme disease, developed by the Vectorborne Subcommittee of the Scientific Subcommittee of the Health Protection Surveillance Centre (HPSC), is available on their website (www.hpsc.ie) to provide members of the general public and media with advice on minimising the risk of Lyme disease. In the future, this committee intends to publish Clinical Guidance on the management of Lyme disease and raising awareness of this condition among clinicians.
